-
-
Categories
-
1-4 of 4
Automated Segmentation of Neural Canal Opening and Optic Cup in 3-D Spectral Optical Coherence Tomography Volumes of the Optic Nerve Head.
Explore NCBI HomePage (Jul 12 2010) Neuro-Ophthalmology
To develop an automated approach for segmenting the neural canal opening (NCO) and cup at the level of retinal pigment epithelium (RPE)/Bruch's membrane (BM) complex in spectral-domain optical coherence tomography (SD-OCT) volumes. (Read Full Article)
Comment Mentions: Cirrus HD-OCT
Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis.
Explore NCBI HomePage (Jul 12 2010) Neuro-Ophthalmology
Scanning laser polarimetry with variable corneal compensation measurements of RNFL thickness corroborates OCT evidence of visual pathway axonal loss in MS and provides new insight into structural aspects of axonal loss that relate to RNFL birefringence (microtubule integrity). (Read Full Article)
Characterization of outer retinal morphology with high-speed, ultrahigh-resolution optical coherence tomography.
Explore NCBI HomePage (Apr 4 2008)
Characterization of outer retinal morphology with high-speed, ultrahigh-resolution optical coherence tomography. Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1571-9 Authors: Srinivasan VJ, Monson BK, Wojtkowski M, Bilonick RA, Gorczynska I, Chen R, Duker JS, Schuman JS, Fujimoto JG PURPOSE: To visualize, quantitatively assess, and interpret outer retinal morphology by ... (Read Full Article)
Comment Mentions: Massachusetts Institute of Technology
Activity of neovascular lesions treated with bevacizumab: comparison between optical coherence tomography and fluorescein angiography.
Explore NCBI HomePage (Jan 17 2007)
Graefes: There is evidence of agreement between both OCT and FA examinations to ascertain the need of re-treatment with bevacizumab for exudative age-related macular degeneration. The OCT was even more sensitive to detect activity of a lesion but fibrotic lesion and PE detachment... (Read Full Article)
1-4 of 4



Recent Comments
Eye on OCT » Contact Us
Zeiss is investigating a range of technologies for the future.
Romar » Contact Us
I would like to know what you think about Swept-Source OCT in glaucoma and if ...
See all recent comments